[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337099-105":59,"doc-detail-337099-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","unlocking-the-dual-role-of-lsd1-in-tumor-immunity-innate-and-adaptive-pathways-review","Unlocking the dual role of LSD1 in tumor immunity - innate and adaptive pathways - review","","Innate and adaptive immunity shape both cancer development and responses to treatment. LSD1 (histone lysine-specific demethylase 1) is frequently overexpressed across many cancers, where it modulates immune checkpoints, immune-cell function, and immunomodulator expression, thereby affecting both immunity arms. Evidence indicates that inhibiting LSD1 can strengthen tumor immunity, reduce tumor growth, and improve immunotherapy efficacy. Yet a unified framework describing LSD1’s roles across innate and adaptive pathways remains incomplete. This review organizes mechanisms and summarizes LSD1 inhibitor progress toward combination immunotherapy strategies.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unlocking-the-dual-role-of-lsd1-in-tumor-immunity-innate-and-adaptive-pathways-review/337099/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unlocking-the-dual-role-of-lsd1-in-tumor-immunity-innate-and-adaptive-pathways-review/337099.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"Why are LSD1 inhibitors considered promising for immunotherapy?","Question",{"text":112,"@type":113},"Inhibiting LSD1 can alter the tumor microenvironment to weaken immunosuppression and enhance antitumor immune responses. Summarized progress suggests potential for improving immunotherapy efficacy, including combination approaches.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},337099,1790750580,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Review  \nIvyspring  \nInternational Publisher  \nTheranostics  \n2024; 14(18): 7054-7071. doi: 10.7150/thno.102037  \nUnlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways  \nYu Zhang1,3, Ningjie Guo1, Haoyi Zhu1, Mengyang Liu1, Jiahui Hao1, Shoukai Wang2, Ting Guo1, MAAMamun4, Jingru Pang1, Qi Liu2, Yichao Zheng1,3, Hongmin Liu1, Pilei Si2􀀍, Lijuan Zhao1􀀍  \n1. State Key Laboratory of Esophageal Cancer Prevention & Treatment; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China; Key Laboratory of Henan Province for Drug Quality and Evaluation, Henan Province; School of Pharmaceutical Sciences; Academy of Medical Sciences; Tianjian Laboratory of Advanced Biomedical Sciences; Zhengzhou University, Zhengzhou, Henan 450001, China.  \n2. Department of Breast Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University;  \nHenan Provincial Engineering Research Center of Breast Cancer Precise Prevention and Treatment, Zhengzhou, Henan 450003, China.  \n3. XNA platform, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.  \n4. School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, China.  \n􀀍 Corresponding authors: Email: xiaoye1695651408@163.com (Lijuan Zhao), [siplei2013@pku.edu.cn](siplei2013@pku.edu.cn) (Pilei Si) .  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [http://ivyspring.com/terms](http://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2024.08.07; Accepted: 2024.10.10; Published: 2024.10.21  \nAbstract  \nThe roles of innate and adaptive immunity are crucial in both the development of cancer and its response to treatment. Numerous studies have demonstrated that histone lysine-specific demethylase 1 (LSD1) is overexpressed in various cancers. Elevated levels of LSD1 intricately modulate immune checkpoints, the function of immune cells, and the expression of immunomodulators, impacting both innate and adaptive immunity. Moreover, compelling evidence suggests that inhibiting LSD1 enhances tumor immunity, suppresses tumor growth, and improves the effectiveness of immunotherapy. However, a comprehensive classification of LSD1’s role in both innate and adaptive immunity is lacking. In this review, we outline the role of LSD1 in tumor immunity in terms of both innate and adaptive immunity, summarizing the mechanisms associated with LSD1-mediated tumor immunity and its potential regulatory capacity in tumor immune escape. Finally, we summarize the research status of LSD1 inhibitors in tumor immunotherapy, which be valuable for promoting the development of effective LSD1-targeted agents used as combination immunotherapy drugs.  \nKeywords: LSD1, Tumor microenvironment, Immune checkpoint blockade, Immune cell, Cancer immunotherapy  \n1. Introduction  \nThe human body maintains health through innate and adaptive immunity, which work to recognize and eliminate damaged and tumor cells. In cancer, both systems play crucial roles [1] . Adaptive immunity, primarily mediated by B and T cells, is central to the fight against cancer and involves several key steps: antigen recognition, clonal expansion, the effector phase, and immune memory [2, 3] . On the other hand, the innate immune system is activated by sensing tissue damage and recruiting cells to the affected areas. For example, macrophages capture and digest diseased cells through phagocytosis, while natural killer (NK) cells can recognize and kill  \ninfected or cancerous cells, suppressing tumor development without the need for antigen presentation [2-4] . The tumor microenvironment (TME) is a complex ecosystem with both pro-tumor and anti-tumor tendencies. It comprises innate immune cells, adaptive immune cells, immunosuppressive cells, ","cbCaijSnCTQPFXvf","https://ap.wps.com/l/cbCaijSnCTQPFXvf","pdf",4236490,18,"English","# Introduction\n## Innate and adaptive immunity in cancer\n## Tumor microenvironment and immune evasion\n# LSD1 and cancer\n## LSD1 as a histone/non-histone demethylase\n## LSD1 expression and clinical relevance\n# (Review content continuation) LSD1 in tumor immunity\n## Innate and adaptive pathway mechanisms\n## LSD1 inhibitors in tumor immunotherapy","[{\"question\":\"Why are LSD1 inhibitors considered promising for immunotherapy?\",\"answer\":\"Inhibiting LSD1 can alter the tumor microenvironment to weaken immunosuppression and enhance antitumor immune responses. Summarized progress suggests potential for improving immunotherapy efficacy, including combination approaches.\"}]","Unlocking the dual role of LSD1 in tumor immunity - innate and adaptive pathways - review | PDF",1790017687,45,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6faf3b82746310b53b0f6b746845c31.webp",983,1272,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3fb73fe355c7ed505a211333012b34c.webp",982,1270,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/328cff90c46d19018c27999f939223db.webp",981,1269,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c5e15916d193c98cc027fa18177b83f.webp",980,1268]